| 000 | 01888 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250512022412.0 | ||
| 264 | 0 | _c19881221 | |
| 008 | 198812s 0 0 eng d | ||
| 022 | _a0004-0010 | ||
| 024 | 7 |
_a10.1001/archsurg.1988.01400360024002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMeyer, J D | |
| 245 | 0 | 0 |
_aTumor necrosis factor-enhanced leukotriene B4 generation and chemotaxis in human neutrophils. _h[electronic resource] |
| 260 |
_bArchives of surgery (Chicago, Ill. : 1960) _cDec 1988 |
||
| 300 |
_a1454-8 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aCalcimycin _xadministration & dosage |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aChemotaxis, Leukocyte _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEndotoxins _xadministration & dosage |
| 650 | 0 | 4 | _aEscherichia coli |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aLeukotriene B4 _xbiosynthesis |
| 650 | 0 | 4 |
_aLipopolysaccharides _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aN-Formylmethionine Leucyl-Phenylalanine _xadministration & dosage |
| 650 | 0 | 4 |
_aNeutrophils _xdrug effects |
| 650 | 0 | 4 | _aStimulation, Chemical |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xadministration & dosage |
| 650 | 0 | 4 |
_aZymosan _xadministration & dosage |
| 700 | 1 | _aYurt, R W | |
| 700 | 1 | _aDuhaney, R | |
| 700 | 1 | _aHesse, D G | |
| 700 | 1 | _aTracey, K J | |
| 700 | 1 | _aFong, Y M | |
| 700 | 1 | _aVerma, M | |
| 700 | 1 | _aShires, G T | |
| 700 | 1 | _aDineen, P | |
| 700 | 1 | _aLowry, S F | |
| 773 | 0 |
_tArchives of surgery (Chicago, Ill. : 1960) _gvol. 123 _gno. 12 _gp. 1454-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/archsurg.1988.01400360024002 _zAvailable from publisher's website |
| 999 |
_c2853548 _d2853548 |
||